Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Immunology

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.clim.2016.05.011PMID 27237127PMCID PMC5193537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.

  2016cited by this paper
• Diversification of TAM receptor function

  2014cited by this paper
• Different expression patterns and clinical significance of mAxl and sAxl in systemic lupus erythematosus

  2014cited by this paper
• Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity

  2013cited by this paper
• Macrophage subpopulations in systemic lupus erythematosus.

  2012cited by this paper
• Macrophages and neutrophils in SLE-An online molecular catalog.

  2012cited by this paper
• Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

  2011cited by this paper
• Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during Experimental Autoimmune Encephalomyelitis

  2011cited by this paper
• Soluble Axl Is Generated by ADAM10-Dependent Cleavage and Associates with Gas6 in Mouse Serum

  2011cited by this paper
• Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus

  2011cited by this paper
• Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation

  2009cited by this paper
• Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus

  2009cited by this paper
• Emphysema Mediated by Lung Overexpression of ADAM10

  2009cited by this paper
• The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.

  2009cited by this paper
• Bone Marrow-Derived Macrophages (BMM): Isolation and Applications.

  2008cited by this paper
• Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1

  2008cited by this paper
• Hyperosmotic stress induces Axl activation and cleavage in cerebral endothelial cells

  2008cited by this paper
• The Immunological Genome Project: networks of gene expression in immune cells

  2008cited by this paper
• Elevated Urinary VCAM-1, P-Selectin, Soluble TNF Receptor-1, and CXC Chemokine Ligand 16 in Multiple Murine Lupus Strains and Human Lupus Nephritis1

  2007cited by this paper
• Macrophages and Dendritic Cells Use Different Axl/Mertk/Tyro3 Receptors in Clearance of Apoptotic Cells1

  2007cited by this paper
• Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis.

  2007cited by this paper
• Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

  2006cited by this paper
• Twist mediates suppression of inflammation by type I IFNs and Axl

  2006cited by this paper
• A Tlr7 translocation accelerates systemic autoimmunity in murine lupus.

  2006cited by this paper
• Soluble Axl Is Generated by ADAM10-Dependent Cleavage and Associates with Gas6 in Mouse Serum

  2005cited by this paper
• Type I interferon correlates with serological and clinical manifestations of SLE

  2005cited by this paper
• Shedding light on ADAM metalloproteinases.

  2005cited by this paper
• Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.

  2005cited by this paper
• Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints.

  2005cited by this paper
• Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.

  2004cited by this paper
• Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells.

  2004cited by this paper
• Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients

  2003cited by this paper
• Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity.

  2003cited by this paper
• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• ADAM‐10 and ADAM‐17 in the inflamed human CNS

  2003cited by this paper
• Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

  2003cited by this paper
• Phagocytosis and clearance of apoptotic cells is mediated by MER

  2001cited by this paper
• Phosphatidylinositol 3-OH Kinase–Akt/Protein Kinase B Pathway Mediates Gas6 Induction of Scavenger Receptor A in Immortalized Human Vascular Smooth Muscle Cell Line

  2001cited by this paper
• Homeostatic Regulation of the Immune System by Receptor Tyrosine Kinases of the Tyro 3 Family

  2001cited by this paper
• Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis.

  2001cited by this paper
• The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes.

  2001cited by this paper
• Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains.

  2000cited by this paper
• ADAM family proteins in the immune system.

  1999cited by this paper
• Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras

  1999cited by this paper
• Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats.

  1998cited by this paper
• Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.

  1997cited by this paper
• New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine.

  1997cited by this paper
• Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins

  1996cited by this paper
• Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase

  1996cited by this paper
• The Transforming Receptor Tyrosine Kinase, Axl, Is Post-translationally Regulated by Proteolytic Cleavage (*)

  1995cited by this paper
• Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.

  1994cited by this paper
• Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus

  1993cited by this paper
• Renal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice

  1963cited by this paper
• Open Access Research

  year unknowncited by this paper

• Sublytic pyroptosis blocks Schwann cell remyelination through caspase-1-mediated Tyro3 cleavage.

  2026cites this paper
• Therapeutic potential of TAM receptors in autoimmune diseases: insights from original studies

  2026cites this paper
• ADAM10: Function insights, disease implications, and promise of therapeutic targeting.

  2025cites this paper
• Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?

  2025cites this paper
• Potential Therapeutic Targets and Emerging Strategies to Promote Hematoma Resolution in Intracerebral Hemorrhage

  2025cites this paper
• From pathogenesis to therapeutic targeting: new insight into TAM receptors in rheumatoid arthritis

  2025cites this paper
• Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3

  2024cites this paper
• Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis

  2024cites this paper
• A Disintegrin and metalloproteinase carves T cell abnormalities and pathogenesis in systemic lupus erythematosus.

  2024cites this paper
• GAS6/TAM Axis as Therapeutic Target in Liver Diseases

  2024cites this paper
• Neutrophil-like pH-responsive pro-efferocytic nanoparticles improve neurological recovery by promoting erythrophagocytosis after intracerebral hemorrhage

  2024cites this paper
• From MASH to HCC: the role of Gas6/TAM receptors

  2024cites this paper
• Gas6/Axl signaling promotes hematoma resolution and motivates protective microglial responses after intracerebral hemorrhage in mice.

  2024cites this paper
• Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?

  2024cites this paper
• Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms

  2024cites this paper
• iRhom2 regulates ectodomain shedding and surface expression of the major histocompatibility complex (MHC) class I

  2024cites this paper
• Efferocytosis: Current status and future prospects in the treatment of autoimmune diseases

  2024cites this paper
• An insight into the TAM system in Alzheimer's disease.

  2023cites this paper
• Influence of serum Gas6 levels on prognosis in patients with hepatocellular carcinoma.

  2023cites this paper
• Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target

  2023cites this paper
• New insights into the function and pathophysiology of the ectodomain sheddase A Disintegrin And Metalloproteinase 10 (ADAM10)

  2023cites this paper
• Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3

  2023cites this paper
• The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus

  2023cites this paper
• Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients

  2023cites this paper
• Up-regulated serum levels of TAM receptor tyrosine kinases in a group of Egyptian autistic children.

  2022cites this paper
• Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis

  2022cites this paper
• TAM Receptors in the Pathophysiology of Liver Disease

  2022cites this paper
• Quantitative Proteomics Reveals That ADAM15 Can Have Proteolytic-Independent Functions in the Steady State

  2022cites this paper
• Drugging the efferocytosis process: concepts and opportunities

  2022cites this paper
• Two-Front War on Cancer—Targeting TAM Receptors in Solid Tumour Therapy

  2022cites this paper
• Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis

  2022cites this paper
• Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus

  2022cites this paper
• Proteinase imbalance in oral cancer and other diseases

  2022cites this paper
• Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium

  2021cites this paper
• Axl is related to inflammation in hemodialysis patients.

  2021cites this paper
• Cardiopulmonary Bypass–Induced Inflammation and Myocardial Ischemia and Reperfusion Injury Stimulates Accumulation of Soluble MER*

  2021cites this paper
• ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1

  2021cites this paper
• Proteolytic Cleavage of Receptor Tyrosine Kinases

  2021cites this paper
• Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus

  2021cites this paper
• Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation

  2021cites this paper
• Influence of leptin and compression in GAS-6 mediated homeostasis of periodontal ligament cell.

  2021cites this paper
• Ars moriendi: Proteases as sculptors of cellular suicide.

  2021cites this paper
• Dihydroartemisinin exerts multiple effects in ameliorating CNS inflammation by enhancing AXL signaling in microglia from mouse model of multiple sclerosis

  2020cites this paper
• Therapeutic aspects of the Axl/Gas6 molecular system.

  2020cites this paper
• The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators That Inhibit Their Activity

  2020cites this paper
• Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer

  2020cites this paper
• Necroptosis, ADAM proteases and intestinal (dys)function.

  2020cites this paper
• Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells

  2020cites this paper
• Association of ADAM17 Expression Levels in Patients with Interstitial Lung Disease

  2020cites this paper
• Differential TAM receptor regulation of hepatic physiology and injury

  2020cites this paper
• Recent advancements in role of TAM receptors on efferocytosis, viral infection, autoimmunity, and tissue repair.

  2020cites this paper
• Shedding of soluble glycoprotein VI is neither affected by animal-derived antibeta-2-glycoprotein 1 antibodies nor IgG fractions from patients with systemic lupus erythematosus.

  2020cites this paper
• Targeting ADAM10 in Cancer and Autoimmunity

  2020cites this paper
• New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis

  2020cites this paper
• TAM receptors in cardiovascular disease

  2019cites this paper
• ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker.

  2019cites this paper
• Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis

  2019cites this paper
• Innate immune-responses and their role in driving autoimmunity.

  2019cites this paper
• A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target

  2019cites this paper
• Regulation of Fibrotic Processes in the Liver by ADAM Proteases

  2019cites this paper
• Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis

  2019cites this paper
• Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target

  2019cites this paper
• Gas6/TAM Receptors in Systemic Lupus Erythematosus

  2019cites this paper
• How macrophages deal with death

  2019cites this paper
• PD-1 immunobiology in systemic lupus erythematosus.

  2019cites this paper
• The effects of vitamin K1 and vitamin K2 on the proliferation, cytokine production and regulatory T‐cell frequency in peripheral blood mononuclear cells of paediatric atopic dermatitis patients

  2018cites this paper
• key roles of axl in systemic lupus erythematosus

  2018cites this paper
• Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction

  2018cites this paper
• Identificación de dianas terapéuticas en fibrosis hepática y cáncer

  2018cites this paper
• Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics

  2018cites this paper
• Renal ADAM10 and 17: Their Physiological and Medical Meanings

  2018cites this paper
• Gamma-secretase-dependent signaling of receptor tyrosine kinases

  2018cites this paper
• Distant Insulin Signaling Regulates Vertebrate Pigmentation through the Sheddase Bace2.

  2018cites this paper
• Irreversible modifications of receptor tyrosine kinases

  2018cites this paper
• The metalloproteinase ADAM10: A useful therapeutic target?

  2017influential citation
• Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage

  2017cites this paper
• Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus.

  2016cites this paper
• Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer

  2016cites this paper
• Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.

  2016cites this paper
• Seminars in Liver Disease GAS6/TAM axis as therapeutic target in liver diseases

  year unknowncites this paper